Abstract
C48.401-Ba cream, containing 0·05% halomethasone* was compared in a double-blind between-patients trial with a cream containing 0·1% betamethasone valerate** in forty-eight patients suffering from atopic dermatitis and in thirty-nine patients suffering from seborrhoeic dermatitis.
A similar comparison was made with ointments containing the same concentration of active ingredient in forty-six patients suffering from atopic dermatitis. Both ointments were also compared in a within-patient double-blind trial in thirty patients suffering from psoriasis.
The analysis of the results showed that for the treatment of the above-mentioned dermatoses, both drugs, the cream as well as the ointment, are equally effective and well tolerated.
Get full access to this article
View all access options for this article.